Skip to content
Search

Latest Stories

Lenmeldy, a lifesaving gene therapy, now the world's most expensive drug

Striking about 1 in 100,000 newborns, MLD is a rare, rapidly worsening, and fatal nervous system disorder.

Lenmeldy, a lifesaving gene therapy, now the world's most expensive drug

Lenmeldy, a new gene therapy for the rare and fatal childhood disease metachromatic leukodystrophy (MLD), has become the world's most expensive drug, at a whopping $4.25 million (£3.350 million).

MLD is a brutal illness that strikes toddlers and affects their ability to walk and talk. It's a heartbreaking reality for families, with roughly half of the afflicted children succumbing to the disease, while the others live on in a vegetative state.


However, MLD is also incredibly rare, affecting only around 40 children annually in the United States. This very rarity lies at the heart of the soaring price tags associated with new gene therapies like Lenmeldy. Consider the economics: Orchard employs a staff of 160, a stark contrast to the limited number of children they can treat over several years.

“My heart wants to talk about what an effect this therapy has had on these children. Without it, they will die very young or live for many years in a vegetative state. But kids who get the gene therapy, mostly end up being able to walk and do well cognitively. The ones we treat are going to school, they’re playing sports, and they are able to tell their stories,” says Orchard’s chief medical officer, Leslie Meltzer.

While the manufacturer, Orchard Therapeutics, justifies this astronomical cost by highlighting the treatment's potential to cure a deadly disease, affordability and accessibility remain major concerns.

This raises questions about the commercial viability of Lenmeldy, even at its current price. Experts predict a challenging journey, citing the past struggles of gene therapies on the market. The European experience with Lenmeldy, approved there three years ago at a slightly lower price, reflects this. Orchard generated a mere $12.7 million (£10.04 million) from sales for most of last year, a clear indication of the limited number of children treated.

Despite the financial concerns, Lenmeldy offers a glimmer of hope. The treatment works by adding a missing gene to a child's bone marrow cells, effectively reversing the root cause of the disease in the brain. Children who participated in trials that began in 2010 are now living normal lives, a testament to the therapy's effectiveness.

Independent groups also support the value of Lenmeldy. The Institute for Clinical and Economic Review, which assesses drug value, estimates the treatment to be cost-effective within a range of £1.8 million to £3.08 million. However, super-high prices can signal economic unsustainability. A previous record holder, the gene therapy Glybera for a different condition, was purchased only once before being pulled from the market due to its $1 million price tag, which couldn't be justified by its limited effectiveness.

gene therapy Five specialised treatment centres being qualified across the US to minimise travel burden on eligible patients and their families (Representative image: iStock)

Hemgenix, a £2.7 million gene therapy for haemophilia, held the title of the most expensive drug until Lenmeldy's arrival. Although these therapies were envisioned to generate billions in sales, news reports suggest a lower-than-expected uptake.

Orchard itself discontinued another gene therapy, Strimvelis, which offered a cure for a specific immune deficiency. The limited patient pool and the existence of an alternative treatment proved to be insurmountable hurdles, even with a money-back guarantee. Orchard was subsequently acquired by the Japanese drug company Kyowa Kirin.

The success of Lenmeldy hinges on early testing. Once symptoms develop, it might be too late. Currently, many cases are identified only because an older sibling succumbed to the inherited condition.

Early detection through newborn screening programs could be a game-changer, allowing for timely intervention and potentially saving countless lives. A decision on newborn screening for MLD is expected in May 2024.

Amy Price, a parent who lost one child to MLD but saved two others with Lenmeldy, exemplifies the human impact of this treatment. Her two treated children are now thriving teenagers.

While acknowledging the high cost, this treatment emphasises the long-term benefits compared to the financial burden of caring for an untreated child.

Lenmeldy represents a significant breakthrough in gene therapy. However, its high cost and the rarity of the disease it treats create significant challenges. Increased access through early testing and insurance coverage will be crucial for maximising the life-saving potential of this groundbreaking treatment.

Teddi Shaw, a toddler with a rare genetic disease, became the first child in the UK in 2023 to receive life-saving gene therapy on the NHS. last year, in February. The treatment, Libmeldy, is very expensive but could not help Teddi's older sister Nala, who was diagnosed too late.

Both girls have MLD, a fatal condition that attacks the brain and nervous system. Nala started showing symptoms first, like uncoordinated walking and tremors. The doctors initially dismissed the parents' concerns but later confirmed it was MLD.

Sadly, by the time Nala was diagnosed, the new gene therapy was no longer an option for her. Now terminally ill, Nala can only receive supportive care.

More For You

Gwyneth Paltrow

Paltrow's interest in wellness and food began in part due to her father’s battle with throat cancer

Getty

Gwyneth Paltrow returns to sourdough and pasta after years of ‘hardcore’ diets

Gwyneth Paltrow has revealed that she is returning to eating foods she once restricted, including sourdough bread, pasta, and cheese, after following a strict paleo diet for several years. The Oscar-winning actress, who has become a prominent health and wellness advocate, has been vocal about her diet choices throughout her career, particularly through her lifestyle business, Goop.

In a recent episode of her Goop podcast, Paltrow discussed her food journey and how her eating habits have evolved over the years. She explained that she had previously gone through a "hardcore macrobiotic" phase, describing it as an "interesting chapter" where she became deeply focused on eating extremely healthy foods. This period saw her embracing a diet rich in seasonal and local foods, with an emphasis on fish, vegetables, and rice, while eliminating dairy and sugar.

Keep ReadingShow less
5 Surprising Penguin Facts to Celebrate World Penguin Day

It’s a perfect opportunity to reflect on these fascinating facts about penguins

iStock

Top 5 fascinating facts about penguins on World Penguin Day

As World Penguin Day arrives, it serves as a reminder to celebrate one of nature’s most beloved and unique creatures. Penguins have long captured our imaginations with their tuxedo-like appearance, charming behaviour, and extraordinary ability to thrive in some of the harshest environments on Earth. While these remarkable birds are most closely associated with the icy expanses of Antarctica, their story is far more diverse and fascinating. Here are five fascinating facts about penguins that highlight their resilience, adaptability, and their role in the animal kingdom.

1. Penguins aren’t confined to Antarctica

Although penguins are often linked with the cold and icy landscapes of Antarctica, they are not confined to this frozen continent. In fact, penguins inhabit a wide range of environments across the Southern Hemisphere. While species such as the Emperor and Adélie penguins breed exclusively in Antarctica, other penguin species have adapted to life in warmer climates. For instance, the Galápagos penguin resides on the Galápagos Islands, located just north of the equator, where temperatures are much warmer than those in the icy waters of the South Pole.

Keep ReadingShow less
Harrogate flower show

Organised by the North of England Horticultural Society

Getty

Harrogate to host UK’s largest flower show with 40,000 visitors

An estimated 40,000 visitors are expected to attend the Harrogate Spring Flower Show over the next four days, making it one of the UK’s largest events for horticulture and floral art. The event, which opened today (Thursday 24 April), is being held at the Great Yorkshire Events Centre in Harrogate and runs daily from 9.30 am to 5 pm until Sunday 27 April.

Organised by the North of England Horticultural Society, the Harrogate Spring Flower Show is recognised for hosting the UK’s biggest exhibition of creative floral art. This year’s floral art theme, Swords & Sorcery: Fantasy Heroes, features imaginative displays inspired by fantasy and mythical tales.

Keep ReadingShow less
Asian community

Menopause is a universal transition - one every woman will experience in her lifetime

iStock

Breaking the silence: Why Asian women must talk about menopause

Kiran Singh

For many women in the Asian community, the journey through perimenopause and menopause is still shrouded in silence, confusion, and, at times, shame. It’s often seen as something we just have to “put up with” quietly, as though struggling through it alone is a badge of honour. But the truth is, menopause is a universal transition - one every woman will experience in her lifetime - and it is time we start talking about it, especially within our cultural communities where silence often masks suffering.

We all go through it - so why don’t we talk about it?

Menopause doesn’t arrive overnight. For most women, it begins subtly during perimenopause, which can start as early as your late 30s or early 40s and last for several years. According to the NHS and the National Institute for Health and Care Excellence (NICE), over 30 recognised symptoms of perimenopause range from hot flushes and night sweats to anxiety, low mood, brain fog, and joint pain.

Keep ReadingShow less
How AI and music could transform dementia care for south Asians

AI tunes into dementia needs

How AI and music could transform dementia care for south Asians

THE recent World Health Congress Awards in Mumbai were a revelation. Stepping into that room overlooking the Arabian Sea, I was surrounded by pioneers and individuals shaping the future of healthcare with bold ideas.

Amid the buzz of innovation, one topic resonated deeply: dementia. It was not just the medical complexities, but the human stories, the silent struggles of carers, and the potential for technology to bridge the widening gaps in care.

Keep ReadingShow less